{"id":58194,"date":"2026-10-05T14:22:58","date_gmt":"2026-10-05T14:22:58","guid":{"rendered":"https:\/\/www.bridge-global.com\/blog\/?p=58194"},"modified":"2026-10-07T09:49:25","modified_gmt":"2026-10-07T09:49:25","slug":"healthcare-interoperability-solution","status":"publish","type":"post","link":"https:\/\/www.bridge-global.com\/blog\/healthcare-interoperability-solution\/","title":{"rendered":"Solutions for Healthcare Interoperability"},"content":{"rendered":"<p>A care coordinator starts Monday by opening the hospital EHR, exporting a medication list, and comparing it with a fax from a behavioral health clinic across the street. The telehealth platform has no connection to either system, so allergies are typed again by hand. The patient&#039;s care team is technically connected to the same person, but the data remains distributed across incompatible systems.<\/p>\n<p>That situation is why solutions for healthcare interoperability must address more than file formats. The engineering challenge includes schema translation, patient identity, consent, provenance, workflow design, security controls, and the small providers that large exchange networks often overlook. FHIR matters, but it doesn&#039;t remove the operational work required to make data trustworthy at the point of care.<\/p>\n<h2>The Fragmented Health Data Problem<\/h2>\n<p>Healthcare data rarely arrives in one clean, authoritative record. A hospital may expose an HL7v2 admission, discharge, and transfer feed, a payer may use X12 transactions, a primary care platform may offer a FHIR endpoint, and a behavioral health clinic may still rely on a desktop application with a proprietary export. Each system represents patients, encounters, medications, and organizations according to its own rules.<\/p>\n<p>The result is distributed clinical state. One system says a medication is active, another says it was discontinued, and a third has no record because the patient changed pharmacies. A patient&#039;s name, date of birth, address, or insurance identifier may differ across identity domains. A consent decision may exist in a document repository but remain invisible to the API handling the request.<\/p>\n<blockquote>\n<p><strong>Practical rule:<\/strong> Treat every external record as a claim with provenance, not as an unquestionable replacement for local data.<\/p>\n<\/blockquote>\n<p>The point-to-point approach fails because each new connection creates another transformation, monitoring surface, credential set, and exception path. It can work for a narrow workflow, such as sending lab results to one known destination, but it becomes fragile when a product must connect hospitals, payers, specialists, pharmacies, home health agencies, and community organizations.<\/p>\n<h3>The long tail changes the architecture<\/h3>\n<p>Large health systems usually have integration teams, interface engines, and established relationships with regional exchanges. Smaller practices often don&#039;t. Behavioral health, post-acute, public health, and community-based organizations may use incomplete APIs, manual exports, or no structured exchange capability at all.<\/p>\n<p>A 2026 survey found that only 18% of organizations could routinely exchange structured, computable data with most behavioral health, post-acute, public health, and community-based partners, while 71% said those partners had limited or no such ability. The leading blockers were integration or transaction fees at 59%, partial or immature APIs at 52%, and slow vendor onboarding at 46%. These figures are reported in <a href=\"https:\/\/www.newswire.com\/news\/the-last-mile-of-interoperability-is-still-manual-for-behavioral-22678941\" target=\"_blank\" rel=\"noopener\">the survey coverage of the last-mile interoperability problem<\/a>.<\/p>\n<p>That last mile deserves the same design attention as the core EHR connection. Teams working on cross-functional data exchange can also learn from approaches to <a href=\"https:\/\/procright.com\/blog\/ai-procurement-breaking-down-silos\" target=\"_blank\" rel=\"noopener\">AI procurement silo solutions<\/a>, where the central problem is not only moving data but giving different teams a usable, governed view of it.<\/p>\n<p>For a deeper treatment of the architecture and organizational causes, see Bridge Global&#039;s <a href=\"https:\/\/www.bridge-global.com\/blog\/healthcare-data-interoperability-challenges\/\">healthcare data interoperability challenges<\/a>. The practical lesson is straightforward: standards create a common language, but identity, consent, ownership, and workflow determine whether anyone can safely use that language.<\/p>\n<h2>The Four Levels of Healthcare Interoperability<\/h2>\n<p>A useful operating model has four levels. Think of sending a clinical record like moving a package through a logistics network. A sealed envelope can travel, but it doesn&#039;t guarantee that the recipient can interpret the contents or coordinate the next delivery.<\/p>\n<p><strong>Foundational interoperability<\/strong> is the transport layer. It includes network connectivity, secure channels, interface endpoints, connectors, and basic message delivery. An HL7v2 feed over MLLP or a secured REST request can move information from one system to another. At this level, the receiving system knows that something arrived, but the content may still require manual interpretation.<\/p>\n<p><strong>Structural interoperability<\/strong> gives the payload a predictable shape. FHIR resources, C-CDA documents, implementation guides, and shared API contracts define where fields belong and how systems should exchange them. A FHIR Patient resource and an Observation resource are more useful than an unstructured document because software can parse them consistently.<\/p>\n<p><strong>Semantic interoperability<\/strong> addresses meaning. Terminology services map local laboratory codes, medication identifiers, diagnoses, and clinical concepts to agreed vocabularies such as LOINC, RxNorm, SNOMED CT, and ICD-10. A blood pressure result isn&#039;t interoperable merely because it sits in an Observation resource. The receiving application also needs to understand the code, unit, reference range, method, and clinical context.<\/p>\n<h3>The organizational level carries the risk<\/h3>\n<p>Organizational interoperability adds policy, governance, accountability, and workflow alignment. It answers questions that APIs can&#039;t resolve:<\/p>\n<ul>\n<li>\n<p>Who may access a record, and for what purpose?<\/p>\n<\/li>\n<li>\n<p>Which organization owns a disputed mapping?<\/p>\n<\/li>\n<li>\n<p>How does a patient revoke consent?<\/p>\n<\/li>\n<li>\n<p>Who reviews an anomalous access event?<\/p>\n<\/li>\n<li>\n<p>What happens when a partner&#039;s data is incomplete?<\/p>\n<\/li>\n<\/ul>\n<p>The 2026 FHIR survey illustrates the movement from experimentation toward governed deployment. Across 101 experts in 63 countries, 62% reported active FHIR use cases in their country, 20% identified FHIR as the primary interoperability standard, and 80% said FHIR was mandated or recommended where national regulation exists. The findings also reported that 74% expected significant national benefits from FHIR adoption by 2029, including cost savings and better care coordination. These figures appear in <a href=\"https:\/\/fire.ly\/news\/state-of-fhir-2026\/\" target=\"_blank\" rel=\"noopener\">the State of FHIR 2026 findings<\/a>.<\/p>\n<p><figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/10\/solutions-for-healthcare-interoperability-implementation-plan.jpg\" alt=\"A 90-day healthcare interoperability implementation plan timeline divided into three phases with specific tasks for each stage.\" \/><\/figure>\n<\/p>\n<p>The survey also identified a versioned ecosystem rather than one permanent baseline. 36% of respondents named FHIR R4 as the main standard in 2026, while eight countries, including Estonia, Kenya, Poland, and the Czech Republic, had identified FHIR R5 as their primary version. That makes version governance part of architecture planning, not a detail to postpone until migration becomes urgent.<\/p>\n<h2>The Technical Stack Behind Modern Interoperability<\/h2>\n<p>A production interoperability platform is a coordinated stack, not a list of fashionable technologies. The right design depends on the workflow, data volume, permitted purpose, and risk profile.<\/p>\n<p>At the exchange layer, HL7v2 remains important for event-driven hospital workflows, particularly ADT messages and laboratory feeds. FHIR R4 and R5 provide resource-based APIs, implementation guides, and web-native exchange. C-CDA still appears in document-oriented exchange, while DICOM handles medical imaging. X12 supports administrative and payer transactions, and IHE profiles help organizations define how standards should work together in a real clinical workflow.<\/p>\n<p>FHIR is valuable because it combines a standardized healthcare data model with RESTful interfaces, messaging, and documents. The model reduces the need to invent a separate payload for every integration, but it doesn&#039;t guarantee that two implementations agree on profiles, required fields, terminology, search behavior, or error handling.<\/p>\n<h3>APIs need operational patterns<\/h3>\n<p>A single-patient REST API works well when a clinician needs a current medication list during an encounter. SMART on FHIR adds application launch and authorization patterns. Subscriptions support event-driven updates when a resource changes. Bulk Data Export addresses population-scale use cases, where requesting records one patient at a time is too slow.<\/p>\n<p>A multi-site study found that certified EHR platforms exported between 5 million and 16 million resources at more than 8,000 resources per minute on Oracle Cerner, and between 1 million and 12 million resources at 1,555 to 2,500 resources per minute on Epic. A custom standards-compliant HIE API exceeded 141 million resources at 12,000 resources per minute. The study is available through <a href=\"https:\/\/escholarship.org\/content\/qt7pg5h82n\/qt7pg5h82n.pdf\" target=\"_blank\" rel=\"noopener\">the analysis of Bulk FHIR export performance<\/a>. The practical conclusion is that Bulk FHIR is an architecture and implementation problem, not merely an endpoint feature.<\/p>\n<p>Integration engines such as Rhapsody, Mirth, and InterSystems IRIS can provide transformation, routing, monitoring, and message replay. Cloud services such as AWS HealthLake and Google Cloud Healthcare API can support managed data services, but they don&#039;t eliminate decisions about profiles, identity, consent, terminology, and retention.<\/p>\n\n\n<figure class=\"wp-block-table\"><table><tr>\n<th>Layer<\/th>\n<th>Representative technologies<\/th>\n<th>Primary role<\/th>\n<\/tr>\n<tr>\n<td>Transport and messaging<\/td>\n<td>HL7v2, MLLP, REST, FHIR, C-CDA, DICOM, X12<\/td>\n<td>Move clinical, imaging, and administrative data<\/td>\n<\/tr>\n<tr>\n<td>API access<\/td>\n<td>SMART on FHIR, OAuth 2.0, Subscriptions, Bulk Data Export<\/td>\n<td>Support user-facing and population-scale exchange<\/td>\n<\/tr>\n<tr>\n<td>Integration runtime<\/td>\n<td>Rhapsody, Mirth, InterSystems IRIS, managed cloud healthcare APIs<\/td>\n<td>Route, transform, validate, retry, and monitor messages<\/td>\n<\/tr>\n<tr>\n<td>Exchange framework<\/td>\n<td>HIEs, QHINs, TEFCA, IHE profiles<\/td>\n<td>Coordinate exchange across organizations<\/td>\n<\/tr>\n<tr>\n<td>Terminology<\/td>\n<td>SNOMED CT, LOINC, RxNorm, ICD-10, ICD-11, USCDI<\/td>\n<td>Preserve clinical meaning across systems<\/td>\n<\/tr>\n<tr>\n<td>Trust and identity<\/td>\n<td>OpenID Connect, SMART scopes, mTLS, consent engines<\/td>\n<td>Authenticate, authorize, and audit access<\/td>\n<\/tr>\n<\/table><\/figure>\n\n\n<p>The CMS interoperability and prior authorization rule shows how these pieces are becoming a required production stack for impacted payers. CMS specifies FHIR R4, US Core IG STU 3.1.1, SMART App Launch, Bulk FHIR, and OpenID Connect for relevant APIs, as documented in the CMS interoperability and prior authorization final rule.<\/p>\n<p>FHIR implementation deserves a focused engineering review, especially around profiles, search behavior, terminology, and version migration. Bridge Global&#039;s guide to <a href=\"https:\/\/www.bridge-global.com\/blog\/fhir-integration-services\/\">FHIR integration services<\/a> is useful background when evaluating that work.<\/p>\n<p>A FHIR resource still needs a reliable identity assertion, a valid consent decision, a permitted purpose, and terminology that the receiving clinician understands. Without those controls, a technically valid resource can still be clinically unsafe.<\/p>\n<h2>A Practical Implementation Roadmap<\/h2>\n<p>Interoperability projects fail early when teams start with endpoints instead of workflows. A disciplined delivery sequence makes the unknowns visible before the project acquires too many partners.<\/p>\n<h3>Start with discovery and profiling<\/h3>\n<p>First, inventory every source and destination system. Record interfaces, owners, data domains, message types, refresh behavior, authentication methods, downtime procedures, and contractual constraints. Interview clinicians and operations staff to identify where manual reconciliation changes a decision or delays care.<\/p>\n<p>Next, profile the actual data. Map candidate fields to FHIR R4 resources and the relevant USCDI version, then identify missing values, conflicting representations, local codes, duplicate patients, and stale records. Terminology reconciliation should cover the vocabularies used in the workflow, such as SNOMED CT, RxNorm, and LOINC. Don&#039;t approve a mapping because the labels appear similar. Require examples, source provenance, review status, and an owner.<\/p>\n<h3>Design governance before production<\/h3>\n<p>Consent capture and revocation need explicit workflow states. Provenance should identify the originating system, author, timestamp, transformation, and confidence where applicable. Stewardship roles should specify who approves a mapping, who handles a data-quality dispute, and who can authorize a production change.<\/p>\n<p>A common failure mode is an unowned mapping table. It works during the pilot, then changes without warning when a source system introduces a local code. Another is treating consent as a one-time checkbox rather than a decision that can be narrowed, revoked, audited, and applied consistently across downstream services.<\/p>\n<h3>Build the integration and test it realistically<\/h3>\n<p>An iPaaS or HL7 engine can handle routing and transformation, while a HIE backbone may provide exchange relationships and trust services. Use SMART on FHIR and OAuth 2.0 for application authorization. Use asynchronous workflows for long-running operations, with Kafka or HL7v2 over MLLP where those patterns fit the source environment.<\/p>\n<p>Validate conformance with Inferno, then run realistic load tests that include retries, incomplete records, duplicate events, partner downtime, and large exports. A sandbox that contains only clean synthetic records won&#039;t expose operational failure modes.<\/p>\n<h3>Roll out by clinical value<\/h3>\n<p>Move from sandbox to one pilot site, then expand only when the workflow and monitoring are stable. Define the pilot&#039;s boundaries in writing. Scope creep often enters through requests to add another source, another clinical domain, or another organization before the original use case has measurable acceptance criteria.<\/p>\n<p><figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/10\/solutions-for-healthcare-interoperability-ai-interoperability.jpg\" alt=\"A diagram illustrating how AI improves healthcare interoperability through entity extraction, provenance flagging, and schema validation.\" \/><\/figure>\n<\/p>\n<p>A CTO should budget for data profiling, governance, partner onboarding, security review, conformance testing, and operational support, not only connector development. The endpoint is a small part of the system.<\/p>\n<h2>Compliance, Security, and the Last-Mile Gap<\/h2>\n<p>Regulatory compliance is a baseline, not evidence that an interoperability service is safe in practice. HIPAA security controls, 42 CFR Part 2 for substance use disorder records, applicable state privacy laws, GDPR for relevant cross-border processing, and CMS interoperability requirements all shape the design. None of them automatically creates a usable consent workflow for a community provider with limited technical staff.<\/p>\n<p>The operational layer needs encryption in transit, usually with TLS and, where appropriate, mutual TLS. It needs OAuth 2.0 scopes and SMART on FHIR authorization for application access, patient consent capture and revocation, immutable audit records, anomaly alerting, key rotation, environment separation, and business associate agreements with downstream vendors. Break-glass access should be explicit, justified, time-bound, and visible to reviewers.<\/p>\n\n\n<figure class=\"wp-block-table\"><table><tr>\n<th>Requirement<\/th>\n<th>Technical control<\/th>\n<th>Operational control<\/th>\n<\/tr>\n<tr>\n<td>Protect electronic health information<\/td>\n<td>Encryption, access control, secrets management, network segmentation<\/td>\n<td>Risk assessments, incident response, workforce training, periodic review<\/td>\n<\/tr>\n<tr>\n<td>Limit access by purpose<\/td>\n<td>OAuth 2.0 scopes, SMART permissions, consent and policy engine<\/td>\n<td>Approval rules, consent operations, exception handling<\/td>\n<\/tr>\n<tr>\n<td>Protect sensitive behavioral health data<\/td>\n<td>Segmented data handling, field-level or resource-level policy enforcement<\/td>\n<td>Part 2 procedures, staff guidance, documented disclosure decisions<\/td>\n<\/tr>\n<tr>\n<td>Prove what happened<\/td>\n<td>Immutable audit logs, timestamped provenance, anomaly detection<\/td>\n<td>Routine review, escalation ownership, retention policy<\/td>\n<\/tr>\n<tr>\n<td>Control third-party exposure<\/td>\n<td>Vendor authentication, least privilege, secure integration boundaries<\/td>\n<td>Business associate agreements, due diligence, offboarding<\/td>\n<\/tr>\n<\/table><\/figure>\n\n\n<p>The <a href=\"https:\/\/www.bridge-global.com\/blog\/healthcare-data-governance-guide\/\">healthcare data governance guide<\/a> provides useful context for assigning ownership across these controls.<\/p>\n<h3>The small-provider problem is structural<\/h3>\n<p>Many long-term care providers, behavioral health organizations, home health agencies, skilled nursing facilities, rural clinics, and community services don&#039;t participate in the same exchange arrangements as major hospitals. A QHIN connection or EHR-mediated workflow may improve access to connected organizations while leaving the least-connected partner dependent on fax, portal downloads, or manual entry.<\/p>\n<p>TEFCA provides a nationwide framework for health information sharing in the United States. Its QHINs form a network-of-networks, and a network seeking QHIN status must be a U.S. entity, complete the application, onboarding, and designation process, and sign the Common Agreement, as described in <a href=\"https:\/\/healthit.gov\/policy\/tefca\/\" target=\"_blank\" rel=\"noopener\">ONC&#039;s TEFCA overview<\/a>. That framework helps establish a trusted floor, but it doesn&#039;t solve every partner&#039;s onboarding cost or technical limitations.<\/p>\n<p>Closing the gap requires a provider directory that stays current, lightweight FHIR options for small practices, support for document and batch exchange where necessary, and direct outreach with audit-ready procedures. The last mile is not a temporary inconvenience. It is part of the product boundary.<\/p>\n<h2>Where AI Actually Changes Interoperability<\/h2>\n<p>AI is useful in interoperability when it reduces repetitive interpretation without hiding uncertainty. It becomes risky when it alters clinical meaning without notice.<\/p>\n<p>A practical first use case is named-entity extraction from clinical notes. An NLP service can identify a medication, diagnosis, allergy, or laboratory result and propose a FHIR representation. The proposed resource should retain source text, location, author, timestamp, and transformation metadata. It should also carry a provenance flag or review status rather than overwriting a structured field as if the extraction were authoritative.<\/p>\n<p>Embedding-based terminology mapping can accelerate reconciliation across SNOMED CT, ICD-10, RxNorm, and LOINC. It should generate candidates for deterministic review, especially for safety-critical medication, allergy, diagnosis, and dosage codes. A similarity score isn&#039;t a clinical approval.<\/p>\n<h3>Use AI inside controls<\/h3>\n<p>Anomaly detection can examine access logs for unusual break-glass behavior, impossible travel patterns, repeated failed authorization, or access outside a user&#039;s normal workflow. Rules remain necessary, but a model can help identify combinations that are difficult to express manually.<\/p>\n<p>Clinical summarization and risk stratification sit further downstream. They depend on upstream identity resolution, completeness, terminology mapping, timestamps, and provenance. If normalization introduces an error, a model may make that error easier to read and more persuasive.<\/p>\n<p><figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/10\/solutions-for-healthcare-interoperability-interoperability-benchmarks.jpg\" alt=\"A bar chart showing the declining percentage of healthcare systems across four interoperability maturity benchmark levels.\" \/><\/figure>\n<\/p>\n<p>Production governance should include model versioning, drift monitoring, bias evaluation, fallback behavior, human review, and a clear boundary between administrative assistance and clinical decision support. When an AI output influences diagnosis or treatment, the organization may also need to assess whether the functionality falls within applicable medical device or SaMD oversight.<\/p>\n<p>The right framing is not \u201cAI replaces mapping.\u201d It is AI accelerates a governed mapping pipeline. Every proposed transformation still needs validation, provenance, rollback, and an accountable owner.<\/p>\n<h2>Choosing Architecture, Vendors, and Metrics That Matter<\/h2>\n<p>There are three common architecture patterns, and each solves a different problem.<\/p>\n<p><strong>Point-to-point APIs<\/strong> are appropriate for a small number of stable, high-value workflows. They offer direct control and low intermediary complexity, but every new partner adds custom code and operational overhead.<\/p>\n<p><strong>An integration platform or HL7 engine<\/strong> is a better fit when the organization has multiple source systems, transformations, message types, and monitoring requirements. The trade-off is platform cost, specialized skills, and the need to prevent the engine from becoming an opaque collection of custom scripts.<\/p>\n<p><strong>An HIE or TEFCA-mediated model<\/strong> helps when the product needs exchange relationships beyond its own contracts. It can reduce bilateral onboarding, but the organization still has to handle local identity matching, consent, data quality, and partner-specific behavior.<\/p>\n\n\n<figure class=\"wp-block-table\"><table><tr>\n<th>Criterion<\/th>\n<th>Why it matters<\/th>\n<th>How to verify in pilot<\/th>\n<\/tr>\n<tr>\n<td>FHIR R4 and R5 conformance depth<\/td>\n<td>Version labels don&#039;t reveal profile, search, or operation quality<\/td>\n<td>Test representative resources, profiles, searches, errors, and migration behavior<\/td>\n<\/tr>\n<tr>\n<td>SMART on FHIR launch support<\/td>\n<td>App launch must carry the right patient, encounter, and scopes<\/td>\n<td>Run launch tests with clinician, patient, and system contexts<\/td>\n<\/tr>\n<tr>\n<td>Terminology service coverage<\/td>\n<td>Semantic errors can be more dangerous than transport errors<\/td>\n<td>Submit local codes and review mappings, versions, and approval workflows<\/td>\n<\/tr>\n<tr>\n<td>Identity and authorization stack<\/td>\n<td>Authentication alone doesn&#039;t establish permitted use<\/td>\n<td>Test OpenID Connect, SMART scopes, consent decisions, and revocation<\/td>\n<\/tr>\n<tr>\n<td>Consent handling<\/td>\n<td>Sensitive data needs purpose-aware policy enforcement<\/td>\n<td>Exercise grant, restriction, revocation, and emergency access scenarios<\/td>\n<\/tr>\n<tr>\n<td>Sandbox-to-production path<\/td>\n<td>A clean demo environment can hide deployment risk<\/td>\n<td>Compare configuration, data, monitoring, and rollback between environments<\/td>\n<\/tr>\n<tr>\n<td>Pricing transparency<\/td>\n<td>Per-transaction costs can alter the operating model<\/td>\n<td>Model normal, peak, retry, and bulk exchange volumes using written terms<\/td>\n<\/tr>\n<\/table><\/figure>\n\n\n<p>Track outcomes that matter to clinicians and the board, not only uptime or connection counts. Five useful measures are record retrieval p95 latency, mapping accuracy on a held-out test set, duplicate record rate, clinician override rate on AI-normalized data, and the percentage of relevant external records surfaced during the encounter.<\/p>\n<p>These metrics expose whether the service is usable, trusted, and clinically relevant. A dashboard showing many active connections may look healthy while clinicians still can&#8217;t find an external discharge summary when they need it.<\/p>\n<p>Healthcare interoperability has become a substantial market. One 2026 estimate valued the global market at USD 6.68 billion in 2025 and projected USD 16.49 billion by 2034, with a 10.64% CAGR and North America holding a 45.80% share in 2025, as reported by <a href=\"https:\/\/www.fortunebusinessinsights.com\/healthcare-interoperability-market-105818\" target=\"_blank\" rel=\"noopener\">Fortune Business Insights<\/a>. That investment makes vendor diligence more important, not less. A large category contains many products that solve connectivity while leaving governance and last-mile adoption to the buyer.<\/p>\n<h2>Starting Your Interoperability Program<\/h2>\n<p>A credible starting plan can fit into three delivery phases.<\/p>\n<p>During days 1 to 30, map data sources and owners, inventory HL7v2 feeds, custom APIs, flat files, portals, and manual workflows. Choose two or three concrete use cases, such as admission-discharge-transfer reconciliation or external laboratory ingestion, and estimate their operational value from current work rather than a generic transformation narrative.<\/p>\n<p>During days 31 to 60, stand up a FHIR R4 server or gateway, define a minimal identity and consent model, and run a one-partner sandbox pilot. Agree on success criteria before building. Include data completeness, retrieval latency, mapping review, authorization behavior, and failure recovery.<\/p>\n<p>During days 61 to 90, instrument the operational metrics, document security controls for HIPAA review, test realistic load and downtime scenarios, and produce a board-ready scope for the next two quarters. If the team needs broader infrastructure and support around clinical environments, a practical review of <a href=\"https:\/\/www.datalunix.com\/post\/managed-it-services-for-healthcare\" target=\"_blank\" rel=\"noopener\">IT services for hospitals<\/a> can help frame the operational boundary.<\/p>\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/10\/solutions-for-healthcare-interoperability-implementation-timeline.jpg\" alt=\"A bar chart titled Implementation Timeline by Phase showing progress across three quarters for various project stages.\" \/><\/figure>\n<h2>Questions that Stop Committees<\/h2>\n<h3>Should we build or buy?<\/h3>\n<p>Buy or reuse commodity transport, authentication, and exchange capabilities where they meet your requirements. Build the workflow-specific mapping, governance, and product experience that differentiate your service.<\/p>\n<h3>When should we join TEFCA?<\/h3>\n<p>Consider it when nationwide exchange relationships, permitted purposes, and partner reach justify the onboarding and governance work. It won&#8217;t replace local consent, identity, or data-quality engineering.<\/p>\n<h3>How long does a real pilot take?<\/h3>\n<p>The answer depends on the number of systems, partner readiness, data domains, security review, and clinical scope. A pilot is ready when it can demonstrate the agreed workflow under realistic failure conditions, not when a demo endpoint returns a successful response.<\/p>\n<h3>Should we wait for FHIR R5?<\/h3>\n<p>Don&#8217;t delay a valuable workflow solely for a future version. Build a version-aware interface, isolate profiles and mappings, and document the migration path. The choice between R4 and R5 should follow partner readiness, regulatory requirements, and the resources your use case needs.<\/p>\n<hr \/>\n<p>Bridge Global helps healthtech teams design and build standards-based healthcare software, including HL7 and FHIR integrations, secure data exchange, healthcare SaaS, and AI-assisted product engineering. Visit <a href=\"https:\/\/www.bridge-global.com\">Bridge Global<\/a> to discuss an interoperability roadmap grounded in your systems, workflows, governance requirements, and measurable pilot outcomes.<\/p><!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>A care coordinator starts Monday by opening the hospital EHR, exporting a medication list, and comparing it with a fax from a behavioral health clinic across the street. The telehealth platform has no connection to either system, so allergies are &hellip;<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":165,"featured_media":58193,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1015],"tags":[1216,1368,1369,1962,1132],"class_list":["post-58194","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","tag-ehr-integration","tag-healthcare-interoperability","tag-fhir","tag-interoperability-solutions","tag-healthtech"],"featured_image_src":"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/10\/solutions-for-healthcare-interoperability-medical-technology.jpg","author_info":{"display_name":"Upendra Jith","author_link":"https:\/\/www.bridge-global.com\/blog\/author\/upendrajith\/"},"_links":{"self":[{"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/posts\/58194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/users\/165"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/comments?post=58194"}],"version-history":[{"count":2,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/posts\/58194\/revisions"}],"predecessor-version":[{"id":58218,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/posts\/58194\/revisions\/58218"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/media\/58193"}],"wp:attachment":[{"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/media?parent=58194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/categories?post=58194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/tags?post=58194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}